Insider Buying Report: Dominion Energy and Cryo-Cell International
PorAinvest
jueves, 28 de agosto de 2025, 11:18 am ET1 min de lectura
CCEL--
At Dominion Energy, Robert M. Blue, the Chair, President, and CEO, purchased 4,152 shares of the company's common stock. The purchase was made at a weighted average price of $60.346 per share, totaling $250,556 [1]. This marks the first insider buy by Blue in the past year. Following the transaction, Blue directly owns 161,236 shares and indirectly owns 4,330 shares through a Trustee of Employee Savings Plan. As of Thursday, Dominion Energy's stock was trading flat.
Meanwhile, David Portnoy, Chairman and Co-CEO of Cryo-Cell International, purchased 39,179 shares of the company's stock for $176,198 [2]. This buy was made at a cost of $4.50 per share. Portnoy's latest acquisition is the second purchase in the past year, following two previous buys totaling $109,383 at an average of $4.35 per share. Cryo-Cell International's stock was trading up by 8.2% on Thursday.
These insider buying activities suggest a positive outlook from the executives on the future performance of their respective companies. However, it is essential for investors to consider these transactions in the broader context of the companies' financial health and market conditions.
References:
[1] https://www.tradingview.com/news/tradingview:45e49912cd889:0-dominion-energy-s-ceo-robert-m-blue-buys-company-shares/
[2] https://www.nasdaq.com/articles/thursday-8-28-insider-buying-report-d-ccel
D--
Dominion Energy CEO Robert M. Blue bought 4,152 shares of D for $250,557, while Chairman, Co-CEO David Portnoy purchased 39,179 shares of Cryo-Cell International for $176,198. Both transactions occurred on Wednesday, with Dominion Energy trading flat and Cryo-Cell International up 8.2% on Thursday. These purchases mark the first and second buys by Blue and Portnoy, respectively, in the past year.
On Wednesday, August 27, 2025, significant insider buying activity was reported at two prominent companies: Dominion Energy and Cryo-Cell International. The transactions highlight the confidence of top executives in their respective companies' prospects.At Dominion Energy, Robert M. Blue, the Chair, President, and CEO, purchased 4,152 shares of the company's common stock. The purchase was made at a weighted average price of $60.346 per share, totaling $250,556 [1]. This marks the first insider buy by Blue in the past year. Following the transaction, Blue directly owns 161,236 shares and indirectly owns 4,330 shares through a Trustee of Employee Savings Plan. As of Thursday, Dominion Energy's stock was trading flat.
Meanwhile, David Portnoy, Chairman and Co-CEO of Cryo-Cell International, purchased 39,179 shares of the company's stock for $176,198 [2]. This buy was made at a cost of $4.50 per share. Portnoy's latest acquisition is the second purchase in the past year, following two previous buys totaling $109,383 at an average of $4.35 per share. Cryo-Cell International's stock was trading up by 8.2% on Thursday.
These insider buying activities suggest a positive outlook from the executives on the future performance of their respective companies. However, it is essential for investors to consider these transactions in the broader context of the companies' financial health and market conditions.
References:
[1] https://www.tradingview.com/news/tradingview:45e49912cd889:0-dominion-energy-s-ceo-robert-m-blue-buys-company-shares/
[2] https://www.nasdaq.com/articles/thursday-8-28-insider-buying-report-d-ccel

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios